Table 2.
Novel drug delivery systems for antiacne agent.
Novel drug delivery carrier | Drug entrapped | Method of preparation | Problem statement | Advantages | Reference |
---|---|---|---|---|---|
Nanoparticles | Chitosan Alginate | Ultrasonication | Low solubility | Enhanced antimicrobial activity | [128] |
Minocycline | Ion pairing | Lack of drug loading and entrapment efficiency due to hydrophilicity of the drug | Enhanced drug loading and entrapment efficiency and controlled release | [129] | |
Azelaic acid | Emulsification solvent diffusion | Fewer side effects | Enhanced drug retention at PSU and stability | [130] | |
Triclosan | Solvent displacement | Insufficient permeation and absorption via cutaneous route | Non-irritant to skin, enhanced stability | [131] | |
Cyproterone acetate | Ultrasonication | Systemic antiandrogenic effects | Increased skin penetration and absorption | [132] | |
Garcinia mangostana | Solvent Displacement; Ion gelation reaction |
Water insolubility | Increased follicular penetration and absorption; Increased therapeutic activity | [133, 134] | |
| |||||
Niosomes | Gallidermin | Freeze drying | For oral administration only and systemic pass demerits | Topical formulation with enhanced chemical stability | [135] |
Tretinoin | Thin film hydration | Photodegradation | Increased accumulation in superficial stratum and stability, Increased drug release and entrapment efficiencies | [136, 137] | |
Rosmarinic acid | Reverse phase evaporation | Low water solubility | Increased skin retention of drug and facilitated prolong release | [121] | |
| |||||
Liposomes | Isotretinoin | Sonication | Skin irritation, very low water solubility, difficulty to incorporate in topical base, photodegradation | Potential for skin targeting, prolonging drug release, reduction of photodegradation and skin irritation | [138] |
Clindamycin hydrochloride | Film formation | Lesser reduction in number of lesions | Enhanced antiacne activity and sustained release of drug | [139] | |
Finasteride | Film formation | Only oral administration possible | Topical application with enhanced drug concentration | [140] | |
Tretinoin | Film formation | Skin irritant, photo instability | Enhanced local tolerability and 5-6 times increase comedolytic activity, Reduced photo instability |
[141, 142] | |
Tea tree oil | Ultrasonication | Lesser absorption via follicular route | Facilitated follicular route absorption | [143] | |
Salicylic acid | Thin film hydration | Skin irritant | Increased entrapment efficiency and stability | [144] | |
Cyproterone acetate | — | Systemic antiandrogenic effects | Increased activity by reducing acne lesions and adverse effects | [145] | |
Benzoyl peroxide | Film hydration | Skin irritation | Improved antibacterial activity, reduced irritation | [146] | |
| |||||
Solid lipid nanoparticles | Isotretinoin | Microemulsification | Teratogenicity, mucocutaneous problems like cheilitis, dermatitis, conjunctivitis, blepharitis, skin fragility and xerosis, psychological disorders, erythema, dryness, itching, stinging, skin peeling | Reduced dermal irritation, increased therapeutic performance | [147] |
Retinoic acid | Hot melt homogenization | Sensitive to sunlight, eczematous irritation, erythema, interaction with other applied products | Comedolytic effect, reduction in RA induced irritation | [148] | |
Neem oil | Double emulsification | Lesser drug absorption | Prolonged treatment of acne | [149] | |
Tretinoin | Hot high pressure homogenization | Skin irritation and chemical instability | High encapsulation efficacy, physical stability and absence of cytotoxicity | [127] | |
Terbinafine hydrochloride | Solvent Injection | Longer duration of treatment | Controlled release, drug targeting | [150] | |
| |||||
Nanosuspension | Tretinoin | Precipitation | Poor water solubility and photostability | Improved drug permeation and UV irradiation stability | [151] |
| |||||
Nanoemulsion | Tretinoin, Tetracycline | Sonication | Skin irritation, a burning sensation, and peeling | Enhanced drug permeation and antibacterial activity | [152] |
| |||||
Nano lipid carriers | Tretinoin, Tetracycline | Sonication | Skin irritation, a burning sensation, and peeling | Enhanced drug permeation and antibacterial activity | [152] |
| |||||
Microemulsions | Azelaic acid | — | Large and frequent dosing | Enhanced stability | [153] |
Niflumic acid | Homogenization | Weak solubility in oil and aqueous phases | Increased bioavailability at lesser concentration | [154] | |
Retinoic acid | Homogenization | Systemic side effects | Enhanced skin accumulation of retinoic acid | [155] | |
| |||||
Microspheres | Benzoyl peroxide | Emulsification | Skin irritation | Appropriate reduction in P. acnes count, reduced skin irritation | [156] |
Retinoid | Emulsification | Skin irritation and instability | Reduced irritation and enhanced stability | [157] | |
| |||||
Hydrogel Patches | Triclosan | Film gelation | Insufficient permeation and absorption via cutaneous route | Enhanced transdermal penetration | [158] |